Champions Oncology Inc (CSBR)

1.70
NASDAQ : Health Care
Prev Close 1.66
Day Low/High 1.65 / 1.71
52 Wk Low/High 1.11 / 6.34
Avg Volume 58.20K
Exchange NASDAQ
Shares Outstanding 10.97M
Market Cap 18.21M
EPS -1.30
Div & Yield N.A. (N.A)

Latest News

Champions Oncology, Inc. Announces Pricing Of Public Offering Of Common Stock

Champions Oncology, Inc. Announces Pricing Of Public Offering Of Common Stock

2,000,000 Shares Priced at $2.25 Per Share

Champions To Present At The 28th Annual ROTH Capital Conference On March 16, 2016

Champions To Present At The 28th Annual ROTH Capital Conference On March 16, 2016

Presentation at 10:30 a.m. (PDT)

Icahn School Of Medicine At Mount Sinai And Champions Oncology Initiate Study Evaluating TumorGrafts' Ability To Predict Treatment Benefit In Patients With Triple-Negative Breast Cancer

Icahn School Of Medicine At Mount Sinai And Champions Oncology Initiate Study Evaluating TumorGrafts' Ability To Predict Treatment Benefit In Patients With Triple-Negative Breast Cancer

Side-By-Side Genomic Analysis of Patients' Tumor and TumorGraft Mouse Avatars Before and After Treatment Also to be Conducted

Publication Of Article In Cancer Supports Use Of Personalized Mouse Avatars To Predict Treatment Benefit In Patients

Publication Of Article In Cancer Supports Use Of Personalized Mouse Avatars To Predict Treatment Benefit In Patients

Champions TumorGraftsa¿¢ Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma